ANI debuts generic FleqsuvyGeneric Fleqsuvy is a treatment for spasticity from multiple sclerosis, spinal cord injuries and other spinal cord diseases. CVS Health works to increase value-based health care access in South Carolina inVio Health Network and CVS Health’s Accountable Care Organization are partnering on a program aimed at improving the quality and health of 60,000 Medicare beneficiaries. The Ginger People debuts new lozenges The Ginger Rescue Lozenges are available in hard and soft formats. NACDS highlights CDC study that underscores crucial role of pharmacy A new CDC study underscores scalability of pharmacy-based services for future public health emergencies. Avenacy debuts generic DDAVP Desmopressin acetate for injection is multi-indicated for patients with central diabetes insipidus, hemophilia A and von Willebrand’s disease. Intuity Medical partners with HealthHavenRx online pharmacy platform By enabling an online pharmacy solution, people with diabetes can now obtain POGO Automatic online in addition to physical pharmacy stores. NCPA launches CORE leadership program Skills in financials, operations, marketing and leadership are the focus of the program. Samsung Bioepis releases Q2 2024 U.S. biosimilar market report As of April 2024, the FDA has approved a total of 48 biosimilars across 15 unique biological molecules, and of the 48 approvals, 38 biosimilars have launched in the U.S. market, per the report. Aetna Better Health of Michigan recommended for CHCP contract The Comprehensive Health Care Program covers support of populations eligible for a variety of programs. Lupin gets approval for generic Ingrezza, launches generic Oracea Lupin is one of the first ANDA applicants for generic Ingrezza and is eligible for 180 days of shared generic exclusivity. First Previous 55 56 57 58 59 Next Last